Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 96.89%
March 31, 2026 -994.2%
December 31, 2025 95.24%
September 30, 2025 -746.1%
June 30, 2025 -58.93%
March 31, 2025 -131.5%
December 31, 2024 30.45%
September 30, 2024 -39.73%
June 30, 2024 -1.04K%
March 31, 2024 -369.9%
December 31, 2023 -91.76%
September 30, 2023 31.82%
June 30, 2023 8.28%
March 31, 2023 7.26%
September 30, 2022 57.89%
Date Value
June 30, 2022 80.62%
March 31, 2022 62.40%
December 31, 2021 90.20%
September 30, 2021 0.00%
June 30, 2021 0.00%
March 31, 2021 0.00%
December 31, 2020 0.00%
September 30, 2020 0.00%
June 30, 2020 0.00%
March 31, 2020 0.00%
December 31, 2019 0.00%
September 30, 2019 0.00%
June 30, 2019 0.00%
March 31, 2019 0.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Xencor, Inc. 95.24%
UroGen Pharma Ltd. 90.93%
Ironwood Pharmaceuticals, Inc. 99.60%
Viking Therapeutics, Inc. --
IDEAYA Biosciences, Inc. 87.21%

Gross Profit Margin (Quarterly) Related Metrics